---All---
  • ---All---
  • Accession
  • Catalog #

Myb Sumoylation Site AntibodyPeptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP2500a 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP2500a-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

Myb Sumoylation Site Antibody - Product info

ApplicationIHC, WB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP10242
ReactivityMouse
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW72341 Da

Myb Sumoylation Site Antibody - Additional info

Gene ID 4602
Other Names
MYB; Transcriptional activator Myb; Proto-oncogene c-Myb
Target/Specificity
This Myb Sumoylation Site antibody is generated from rabbits immunized with the KLH conjugated synthetic peptide PLLKKIKQEVESPTCA containing a predicted sumoylation site from the C-terminal region of human HSF2.
Dilution
IHC~~1:50~100
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
Myb Sumoylation Site Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

Myb Sumoylation Site Antibody - Protein Information

Name MYB
Function
Transcriptional activator; DNA-binding protein that specifically recognize the sequence 5'-YAAC[GT]G-3'. Plays an important role in the control of proliferation and differentiation of hematopoietic progenitor cells
Cellular Location
Nucleus.

Myb Sumoylation Site Antibody - Related products

AP2500a: Myb Sumoylation Site Antibody

RI13438: MYB predesign siRNA

AJ1192a: c-Myb Antibody

AF1700a: MYB / c-myb Antibody

Myb Sumoylation Site Antibody - Application data

  • Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

  • Myb Antibody (Sumo) (Cat. #AP2500a) western blot analysis in mouse heart tissue lysates (35ug/lane).This demonstrates the Myb antibody detected the Myb protein (arrow).

Myb Sumoylation Site Antibody - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Myb is a transcriptional activator; DNA-binding protein that recognizes the sequence 5'-YAAC[GT]G-3'. It participates in the control of proliferation and differentiation of hematopoietic progenitor cells. Myb is a transcription factor related to Myc, and is expressed predominantly in haematopoietic cells and immature gastroepithelial cells. TRAF7 stimulates the sumoylation of Myb at Lys-523 and Lys-499, which are the same sites as those used for PIASy-induced sumoylation. A correlation has been established between reduction in sumoylation of Myb and increase in transcriptional activation. Negative influence on transactivation properties by the negative regulatory domain region of c-Myb depends on upon sumoylation.

REFERENCES

Luchetti, M.M., et al., J. Biol. Chem. 278(3):1533-1541 (2003). Dahle, O., et al., Eur. J. Biochem. 270(6):1338-1348 (2003). Chen, J., et al., Oncogene 21(12):1859-1869 (2002). Hernandez-Munain, C., et al., J. Immunol. 169(8):4362-4369 (2002). Tanno, B., et al., J. Biol. Chem. 277(26):23172-23180 (2002).